Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
7 Results Found
CVS Health Upends the Diabetes Drug Market
With rising prices for insulin and the costs of many other diabetes-related drugs taking their toll on patients, CVS Health recently announced that its pharmacy benefits management unit CVS Caremark is launching a program to enable employers and payers to offer these medications at no out-of-pocket costs to members.
Grapefruit Health Targets a New Way to Address the Field’s Workforce Shortage
Ballad Health in Johnson City, Tennessee, recently completed an interesting pilot to improve communication around medication adherence. It worked with Grapefruit Health, a startup focused on addressing health care’s staffing shortage by creating a workforce solely comprising clinical students.
Civica Rx Gets More Backing in Effort to Reduce Drug Prices and Shortages
The state of California put up $50 million to have Civica Rx manufacture and distribute low-cost biosimilars for the three most used short- and long-acting insulins.
3 Takeaways from the HLTH Conference
Amid the sound bites and substance delivered at the recent HLTH conference, health care leaders, transformers and innovators shared how they plan to reshape care delivery, partner to drive innovation and help consumers get greater access to obesity and diabetes medications along with a greater holistic focus on weight management.
Hospital-Led Innovation Efforts Produce Results
Navv Systems Inc., born out of Henry Ford Health System, will use the injection of a $3.2 million venture capital seed round to bolster its pipeline of health care systems focused on better tracking of equipment and personnel, as well as helping patients and visitors better navigate complex facilities.
3 Ways Pharma Could Jolt Health Care in 2023
The market for biosimilar drugs to treat cancer, inflammatory diseases, diabetes and more will continue to expand, ideally resulting in lower prices as more pharmaceutical patents expire and competitors enter the market.
COVID-19 Didn’t Stop Health Care Disruptors from Moving Forward
Amid the COVID-19 pandemic turbulence last year, some of America’s largest companies were forced to reexamine their strategies to disrupt health care in an effort to reduce costs, increase access and forge stronger bonds with consumers. Some, like Amazon, CVS Health, Walgreens Boots Alliance and Walmart, added to the number of their early brick-and-mortar primary care locations to serve their customers or employees.